MY135292A - Novel piperidine derivatives and their use as monoamine neurotransmitter re-uptake inhibitors - Google Patents
Novel piperidine derivatives and their use as monoamine neurotransmitter re-uptake inhibitorsInfo
- Publication number
- MY135292A MY135292A MYPI20034180A MYPI20034180A MY135292A MY 135292 A MY135292 A MY 135292A MY PI20034180 A MYPI20034180 A MY PI20034180A MY PI20034180 A MYPI20034180 A MY PI20034180A MY 135292 A MY135292 A MY 135292A
- Authority
- MY
- Malaysia
- Prior art keywords
- piperidine derivatives
- uptake inhibitors
- monoamine neurotransmitter
- novel piperidine
- novel
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
- C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
THIS INVENTION RELATES TO NOVEL PIPERIDINE DERIVATIVES USEFUL AS MONOAMINE NEUROTRANSMITTER RE-UPTAKE INHIBITORS.IN OTHER ASPECTS, THE INVENTION RELATES TO THE USE OF THESE COMPOUNDS IN A METHOD FOR THERAPY AND TO PHARMACEUTICAL COMPOSITIONS COMPRISING THE COMPOUNDS OF THE INVENTION.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DKPA200201689 | 2002-11-01 | ||
DKPA200300727 | 2003-05-13 |
Publications (1)
Publication Number | Publication Date |
---|---|
MY135292A true MY135292A (en) | 2008-03-31 |
Family
ID=35295048
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MYPI20034180A MY135292A (en) | 2002-11-01 | 2003-10-31 | Novel piperidine derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
Country Status (7)
Country | Link |
---|---|
KR (1) | KR20050071647A (en) |
AR (1) | AR041879A1 (en) |
MY (1) | MY135292A (en) |
NO (1) | NO20052624L (en) |
NZ (1) | NZ538514A (en) |
RU (1) | RU2325378C2 (en) |
TW (1) | TW200504017A (en) |
-
2003
- 2003-10-30 TW TW092130215A patent/TW200504017A/en unknown
- 2003-10-30 NZ NZ538514A patent/NZ538514A/en unknown
- 2003-10-30 KR KR1020057007602A patent/KR20050071647A/en not_active Application Discontinuation
- 2003-10-30 RU RU2005107417/04A patent/RU2325378C2/en not_active IP Right Cessation
- 2003-10-30 AR ARP030103978A patent/AR041879A1/en not_active Application Discontinuation
- 2003-10-31 MY MYPI20034180A patent/MY135292A/en unknown
-
2005
- 2005-05-31 NO NO20052624A patent/NO20052624L/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
RU2325378C2 (en) | 2008-05-27 |
NO20052624L (en) | 2005-05-31 |
TW200504017A (en) | 2005-02-01 |
AR041879A1 (en) | 2005-06-01 |
NZ538514A (en) | 2007-09-28 |
RU2005107417A (en) | 2006-01-20 |
KR20050071647A (en) | 2005-07-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PL1797088T3 (en) | Novel chromen-2-one derivatives and their use as monoamine neurotransmitter re-uptake inhibitors | |
TW200604173A (en) | Novel compounds | |
WO2004113297A3 (en) | Aza-ring derivatives and their use as monoamine neurotransmitter re-uptake inhibitors | |
NO20060360L (en) | New 8-azabicyclo [3.2.1] octane derivatives and their use as monoamine neurotransmitter reuptake inhibitors | |
MY140840A (en) | Acylated, heteroaryl-condensed cycloalkenylamines and their use as pharmaceuticals | |
TW200514772A (en) | Novel tetrahydropyridine derivatives | |
HK1100559A1 (en) | N-aryl piperidine substituted biphenylcarboxamides as inhibitors of apolipoprotein b | |
MX2009005916A (en) | Novel chromen-2-one derivatives and their use as monoamine neurotransmitter re-uptake inhibitors. | |
TW200800980A (en) | Novel compounds | |
MXPA05013758A (en) | Pharmaceutical compositions including an antihistamine and a stimulant and use thereof. | |
TW200508195A (en) | 3-aminopyrrolidines as inhibitors of monoamine uptake | |
MX2010001075A (en) | N-piperidin-4-ylmethyl-amide derivatives and their use as monoamine neurotransmitter re-uptake inhibitors. | |
IS8211A (en) | Diphenylurea derivatives and their use as chlorine barrier inhibitors | |
MXPA05008314A (en) | 8-aza-bicyclo (3.2.1) octane derivatives and their use as monoamine neurotransmitter re-uptake inhibitors. | |
PL375163A1 (en) | Novel piperidine derivatives and their use as monoamine neurotransmitter re-uptake inhibitors | |
WO2006075004A3 (en) | 3, 8 - substituted 8-aza-bicyclo[3.2.1] octane derivatives and their use as monoamine neurotransmitter re-uptake inhibitors | |
MX2009006213A (en) | Novel chromen-2-one derivatives and their use as monoamine neurotransmitter re-uptake inhibitors. | |
MX2007002384A (en) | Novel chromen-2-one derivatives and their use as monoamine neurotransmitter re-uptake inhibitors. | |
TW200603803A (en) | Novel compounds | |
MY135292A (en) | Novel piperidine derivatives and their use as monoamine neurotransmitter re-uptake inhibitors | |
UA89638C2 (en) | Chromen-2-one derivatives and their use as monoamine neurotransmitter re-uptake inhibitors | |
TW200716627A (en) | Novel compounds | |
TW200507844A (en) | 2-methoxymethyl-3-(3,4-dichlorophenyl)-8-azabicyclo[3.2.1]octane tartrate salts | |
TW200603808A (en) | Novel compounds | |
HK1093721A1 (en) | Ibopamine maleate, method for preparing it and pharmaceutical compositions containing it |